Asaya raises Rs 88 crore to expand skincare across online, quick commerce and offline retail

Bengaluru-based D2C skincare brand Asaya has raised Rs 88 crore at a Rs 400 crore post-money valuation from RPSG Capital, OTP Ventures and other investors. The company plans to invest in R&D, product expansion, distribution and hiring.

— Source publishedMon, 24 Aug, 2026, 10:25 IST·First seen Mon, 24 Aug, 2026, 10:27 IST·Source Entrackr · Newsletter

What happened

Bengaluru D2C skincare brand Asaya raised Rs 88 crore at a Rs 400 crore post-money valuation from RPSG Capital, OTP Ventures and others. It will deploy funds

Key facts

  • Rs 88 crore
  • $9.2 million
  • Rs 400 crore post-money valuation
  • Rs 28 crore pre-Series A
  • 2021 founding year
  • Rs 60 crore
  • $5 million
  • Rs 10 crore
  • over Rs 4 crore

Why this matters

Asaya’s funded push into R&D, product expansion and offline distribution makes it a more credible partnership or acquisition-watch candidate for larger beauty and consumer platforms seeking Indian skincare growth.

What to watch

  • New product launches, especially sunscreen, serum, acne, pigmentation and dermatologist-positioned lines.
  • Asaya listings or assortment expansion on Blinkit, Zepto, Swiggy Instamart and major beauty marketplaces.
  • Store-count disclosures, pharmacy/modern-trade partnerships and entry into additional Indian cities.
  • Revenue-growth, repeat-purchase, gross-margin or profitability commentary following the fundraise.
  • Changes in discount intensity, ad visibility and customer ratings relative to competing Indian D2C skincare brands.
  • Senior hiring in R&D, offline sales, supply chain, growth marketing or finance.
  • A larger Series A/B-style fundraising, strategic partnership or acquisition discussions within 12-24 months.
  • Launch adjacent skincare categories and higher-frequency replenishment products, likely targeting acne, pigmentation, sunscreen, barrier repair and body care.
  • Expand hero-SKU availability on leading quick-commerce platforms in major metros, supported by platform promotions and sampling.
  • Increase offline placement through modern trade, pharmacy, beauty specialty and selective general-trade distributors.
  • Build R&D, category, supply-chain and sales teams to support faster product launches and wider retail coverage.
  • Use capital to strengthen marketplace advertising, creator partnerships, dermatology-led credibility and customer-retention programs.
  • Pursue a follow-on fundraise if distribution expansion materially increases working-capital and marketing requirements.

Also reported by